Abstract
The secretion of interleukin-10 by both malignant and immune cells promotes the progression of lung tumors, hence negatively impacting on patient prognosis. As interleukin-10 mediates oncogenic effects through the PI3K/AKT signaling pathway, PI3K/AKT inhibitors might sensitize cancer cells to chemotherapy, thus favoring tumor regression and improving disease outcome.
| Original language | English |
|---|---|
| Article number | e25854 |
| Journal | OncoImmunology |
| Volume | 2 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- CIP2A
- HPV
- IL-10
- IL-10R
- Lung cancer
ASJC Scopus subject areas
- Oncology
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS